19
Participants
Start Date
April 27, 2023
Primary Completion Date
January 17, 2024
Study Completion Date
April 30, 2024
Myrbetriq 25Mg Extended-Release Tablet
Participants take 4x 25mg Myrbetriq 25Mg Extended-Release Tablet orally.
Placebo
Participants take empty capsule orally
Colorado State University, Fort Collins
Indiana University
OTHER
Christopher Bell
OTHER